S

Sarepta Therapeutics
D

SRPT

36.170
USD
-1.08
(-2.90%)
مغلق
حجم التداول
118,633
الربح لكل سهم
2
العائد الربحي
-
P/E
-14
حجم السوق
3,554,680,247
أصول ذات صلة
AMGN
AMGN
-2.10
(-0.70%)
295.22 USD
BIIB
BIIB
-1.660
(-1.25%)
130.660 USD
BMRN
BMRN
-1.000
(-1.75%)
56.220 USD
GILD
GILD
-2.080
(-1.86%)
110.010 USD
INCY
INCY
-1.490
(-2.15%)
67.750 USD
I
IONS
-0.020
(-0.06%)
35.570 USD
R
RCKT
-0.12500
(-4.09%)
2.93500 USD
REGN
REGN
7.50
(1.44%)
529.39 USD
VRTX
VRTX
-4.36
(-0.95%)
455.70 USD
المزيد
الأخبار المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.